Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer

Cancer Letters

Volumn 247, Issue 1-2, 2007, Pages 91-97

  Liu, Mira C P ^a   Choong, David Y H ^a   Hooi, Christine S F ^a   Williams, Louise H ^a   Campbell, Ian G ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Loss of heterozygosity; Methylation; Mutation; TIMP 3; Tumor suppressor

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ARTICLE; CHROMOSOME 22Q; CONTROLLED STUDY; EPIGENETICS; EXON; FEMALE; GENE FREQUENCY; GENE INACTIVATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; METHYLATION; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; RARE DISEASE; SOMATIC MUTATION; TIMP 3 GENE; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 22; DNA METHYLATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MOLECULAR SEQUENCE DATA; MUTATION; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 33845643671     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.03.024     Document Type: Article

References (27)

1. Bryan E.J., Thomas N.A., Palmer K., Dawson E., Englefield P., and Campbell I.G. Refinement of an ovarian cancer tumour suppressor gene locus on chromosome arm 22q and mutation analysis of CYP2D6, SREBP2 and NAGA. Int. J. Cancer 87 (2000) 798-802
2. Bryan E.J., Watson R.H., Davis M., Hitchcock A., Foulkes W.D., and Campbell I.G. Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q. Cancer Res. 56 (1996) 719-721
3. Lin H., Pizer E.S., and Morin P.J. A frequent deletion polymorphism on chromosome 22q13 identified by representational difference analysis of ovarian cancer. Genomics 69 (2000) 391-394
4. Kruzelock R.P., Cuevas B.D., Wiener J.R., Xu F.J., Yu Y., Cabeza-Arvelaiz Y., et al. Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer. Oncogene 19 (2000) 6277-6285
5. Allione F., Eisinger F., Parc P., Noguchi T., Sobol H., and Birnbaum D. Loss of heterozygosity at loci from chromosome arm 22Q in human sporadic breast carcinomas. Int. J. Cancer 75 (1998) 181-186
6. Zhou C.Z., Peng Z.H., Zhang F., Qiu G.Q., and He L. Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma. World J. Gastroenterol. 8 (2002) 668-673
7. Ino Y., Silver J.S., Blazejewski L., Nishikawa R., Matsutani M., von Deimling A., et al. Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade. J. Neuropathol. Exp. Neurol. 58 (1999) 881-885
8. Wild A., Langer P., Celik I., Chaloupka B., and Bartsch D.K. Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions. Eur. J. Endocrinol. 147 (2002) 507-513
9. Bachman K.E., Herman J.G., Corn P.G., Merlo A., Costello J.F., Cavenee W.K., et al. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res. 59 (1999) 798-802
10. Wild A., Ramaswamy A., Langer P., Celik I., Fendrich V., Chaloupka B., et al. Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors. J. Clin. Endocrinol. Metab. 88 (2003) 1367-1373
11. Spurbeck W.W., Ng C.Y., Strom T.S., Vanin E.F., and Davidoff A.M. Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model. Blood 100 (2002) 3361-3368
12. Eads C.A., Lord R.V., Wickramasinghe K., Long T.I., Kurumboor S.K., Bernstein L., et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 61 (2001) 3410-3418
13. Esteller M., Corn P.G., Baylin S.B., and Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res. 61 (2001) 3225-3229
14. Kang G.H., Shim Y.H., Jung H.Y., Kim W.H., Ro J.Y., and Rhyu M.G. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 61 (2001) 2847-2851
15. Lee S., Kim W.H., Jung H.Y., Yang M.H., and Kang G.H. Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma. Am. J. Pathol. 161 (2002) 1015-1022
16. Alonso M.E., Bello M.J., Gonzalez-Gomez P., Arjona D., Lomas J., de Campos J.M., et al. Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas. Cancer Genet. Cytogenet. 144 (2003) 134-142
17. Brock M.V., Gou M., Akiyama Y., Muller A., Wu T.T., Montgomery E., et al. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin. Cancer Res. 9 (2003) 2912-2919
18. Gonzalez-Gomez P., Bello M.J., Alonso M.E., Lomas J., Arjona D., Campos J.M., et al. CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas. Clin. Cancer Res. 9 (2003) 5601-5606
19. Paz M.F., Fraga M.F., Avila S., Guo M., Pollan M., Herman J.G., et al. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 63 (2003) 1114-1121
20. Bryan E.J., Jokubaitis V.J., Chamberlain N.L., Baxter S.W., Dawson E., Choong D.Y., et al. Mutation analysis of EP300 in colon, breast and ovarian carcinomas. Int. J. Cancer 102 (2002) 137-141
21. Campbell I.G., Nicolai H.M., Foulkes W.D., Senger G., Stamp G.W., Allan G., et al. A novel gene encoding a B-Box protein within the BRCA1 region at 17q21.1. Hum. Mol. Genet. 3 (1994) 589-594
22. Dobrovic A., Bianco T., Tan L.W., Sanders T., and Hussey D. Screening for and analysis of methylation differences using methylation-sensitive single-strand conformation analysis. Methods 27 (2002) 134-138
23. Sutherland K.D., Lindeman G.J., Wittlin S., Brentzell L., Phillips W., Campbell I.G., et al. Differential silencing of SOCS genes by hypermethylation in breast and ovarian carcinomas. Oncogene 23 (2004) 7726-7733
24. Nataraj A.J., Olivos-Glander I., Kusukawa N., and Highsmith Jr. W.E. Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection. Electrophoresis 20 (1999) 1177-1185
25. Benetkiewicz M., Wang Y., Schaner M., Wang P., Mantripragada K.K., Buckley P.G., et al. High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas. Genes Chromosomes Cancer 42 (2005) 228-237
26. Kemkemer R., Schrank S., Vogel W., Gruler H., and Kaufmann D. Increased noise as an effect of haploinsufficiency of the tumor-suppressor gene neurofibromatosis type 1 in vitro. Proc. Natl Acad. Sci. USA 99 (2002) 13783-13788
27. Cook W.D., and McCaw B.J. Accommodating haploinsufficient tumor suppressor genes in knudson's model. Oncogene 19 (2000) 3434-3438